Parkinsonism & Related Disorders
Volume 16, Issue 7 , Pages 447-452 , August 2010

GST polymorphisms, interaction with smoking and pesticide use, and risk for Parkinson’s disease in a Japanese population

  • C. Kiyohara

      Affiliations

    • Department of Preventive Medicine, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
    • Corresponding Author InformationCorresponding author. Department of Preventive Medicine, Graduate School of Medical Sciences, Kyushu University, Maidashi 3-1-1, Higashi-ku, Fukuoka 812-8582, Japan. Tel.: +81 92 642 6112.
    • ,
  • Y. Miyake

      Affiliations

    • Department of Public Health, Faculty of Medicine, Fukuoka University, Fukuoka, Japan
    • ,
  • M. Koyanagi

      Affiliations

    • Department of Cell Biology, Faculty of Medicine, Fukuoka University, Fukuoka, Japan
    • ,
  • T. Fujimoto

      Affiliations

    • Department of Cell Biology, Faculty of Medicine, Fukuoka University, Fukuoka, Japan
    • ,
  • S. Shirasawa

      Affiliations

    • Department of Cell Biology, Faculty of Medicine, Fukuoka University, Fukuoka, Japan
    • ,
  • K. Tanaka

      Affiliations

    • Department of Public Health, Faculty of Medicine, Fukuoka University, Fukuoka, Japan
    • ,
  • W. Fukushima

      Affiliations

    • Department of Public Health, Osaka City University Graduate School of Medicine, Osaka, Japan
    • ,
  • S. Sasaki

      Affiliations

    • Department of Social and Preventive Epidemiology, School of Public Health, The University of Tokyo, Tokyo, Japan
    • ,
  • Y. Tsuboi

      Affiliations

    • Department of Neurology, Faculty of Medicine, Fukuoka University, Fukuoka, Japan
    • ,
  • T. Yamada

      Affiliations

    • Department of Neurology, Faculty of Medicine, Fukuoka University, Fukuoka, Japan
    • ,
  • T. Oeda

      Affiliations

    • Clinical Research Institute and Department of Neurology, Utano National Hospital, Kyoto, Japan
    • ,
  • T. Miki

      Affiliations

    • Department of Geriatrics and Neurology, Osaka City University Graduate School of Medicine, Osaka, Japan
    • ,
  • N. Kawamura

      Affiliations

    • Department of Neurology, Neurological Institute, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
    • ,
  • N. Sakae

      Affiliations

    • Department of Neurology, Neurological Institute, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
    • ,
  • H. Fukuyama

      Affiliations

    • Human Brain Research Center, Kyoto University Graduate School of Medicine, Kyoto, Japan
    • ,
  • Y. Hirota

      Affiliations

    • Department of Public Health, Osaka City University Graduate School of Medicine, Osaka, Japan
    • ,
  • M. Nagai

      Affiliations

    • Department of Public Health, Saitama Medical University Faculty of Medicine, Saitama, Japan
    • ,
  • for the Fukuoka Kinki Parkinson’s Disease Study Group

Received 1 February 2010 ,Revised 16 April 2010 ,Accepted 21 April 2010.

References 

  1. Warner TT, Schapira AH. Genetic and environmental factors in the cause of Parkinson’s disease. Ann Neurol. 2003;53(Suppl. 3):S16–S23discussion S-5
  2. Tsang AH, Chung KK. Oxidative and nitrosative stress in Parkinson’s disease. Biochim Biophys Acta. 2009;1792:643–650
  3. Szabo C, Ischiropoulos H, Radi R. Peroxynitrite: biochemistry, pathophysiology and development of therapeutics. Nat Rev Drug Discov. 2007;6:662–680
  4. Reynolds MR, Berry RW, Binder LI. Nitration in neurodegeneration: deciphering the “Hows” “nYs”. Biochemistry. 2007;46:7325–7336
  5. Hayes JD, Pulford DJ. The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit Rev Biochem Mol Biol. 1995;30:445–600
  6. Hayes JD, Flanagan JU, Jowsey IR. Glutathione transferases. Annu Rev Pharmacol Toxicol. 2005;45:51–88
  7. Di Ilio C, Sacchetta P, Iannarelli V, Aceto A. Binding of pesticides to alpha, mu and pi class glutathione transferase. Toxicol Lett. 1995;76:173–177
  8. Kiyohara C, Yamamura KI, Nakanishi Y, Takayama K, Hara N. Polymorphism in GSTM1, GSTT1, and GSTP1 and susceptibility to Lung cancer in a Japanese population. Asian Pac J Cancer Prev. 2000;1:293–298
  9. Priyadarshi A, Khuder SA, Schaub EA, Shrivastava S. A meta-analysis of Parkinson’s disease and exposure to pesticides. Neurotoxicology. 2000;21:435–440
  10. Ritz B, Ascherio A, Checkoway H, Marder KS, Nelson LM, Rocca WA, et al. Pooled analysis of tobacco use and risk of Parkinson disease. Arch Neurol. 2007;64:990–997
  11. Yuille M, Condie A, Hudson C, Kote-Jarai Z, Stone E, Eeles R, et al. Relationship between glutathione S-transferase M1, T1, and P1 polymorphisms and chronic lymphocytic leukemia. Blood. 2002;99:4216–4218
  12. Tanaka-Kagawa T, Jinno H, Hasegawa T, Makino Y, Seko Y, Hanioka N, et al. Functional characterization of two variant human GSTO 1-1s (Ala140Asp and Thr217Asn). Biochem Biophys Res Commun. 2003;301:516–520
  13. Miyake Y, Sasaki S, Tanaka K, Fukushima W, Kiyohara C, Tsuboi Y, et al. Dietary fat intake and risk of Parkinson’s disease: a case-control study in Japan. J Neurol Sci. 2010;288:117–122
  14. Andersson T, Alfredsson L, Kallberg H, Zdravkovic S, Ahlbom A. Calculating measures of biological interaction. Eur J Epidemiol. 2005;20:575–579
  15. Perez-Pastene C, Graumann R, Diaz-Grez F, Miranda M, Venegas P, Godoy OT, et al. Association of GST M1 null polymorphism with Parkinson’s disease in a Chilean population with a strong Amerindian genetic component. Neurosci Lett. 2007;418:181–185
  16. De Palma G, Mozzoni P, Mutti A, Calzetti S, Negrotti A. Case-control study of interactions between genetic and environmental factors in Parkinson’s disease. Lancet. 1998;352:1986–1987
  17. Stroombergen MC, Waring RH. Determination of glutathione S-transferase mu and theta polymorphisms in neurological disease. Hum Exp Toxicol. 1999;18:141–145
  18. Singh M, Khan AJ, Shah PP, Shukla R, Khanna VK, Parmar D. Polymorphism in environment responsive genes and association with Parkinson disease. Mol Cell Biochem. 2008;312:131–138
  19. Ahmadi A, Fredrikson M, Jerregard H, Akerback A, Fall PA, Rannug A, et al. GSTM1 and mEPHX polymorphisms in Parkinson’s disease and age of onset. Biochem Biophys Res Commun. 2000;269:676–680
  20. Bandmann O, Vaughan J, Holmans P, Marsden CD, Wood NW. Association of slow acetylator genotype for N-acetyltransferase 2 with familial Parkinson’s disease. Lancet. 1997;350:1136–1139
  21. Tison F, Coutelle C, Henry P, Cassaigne A. Glutathion S-transferase (class mu) phenotype in Parkinson’s disease. Mov Disord. 1994;9:117–118
  22. Harada S, Fujii C, Hayashi A, Ohkoshi N. An association between idiopathic Parkinson’s disease and polymorphisms of phase II detoxification enzymes: glutathione S-transferase M1 and quinone oxidoreductase 1 and 2. Biochem Biophys Res Commun. 2001;288:887–892
  23. Kelada SN, Stapleton PL, Farin FM, Bammler TK, Eaton DL, Smith-Weller T, et al. Glutathione S-transferase M1, T1, and P1 polymorphisms and Parkinson’s disease. Neurosci Lett. 2003;337:5–8
  24. Menegon A, Board PG, Blackburn AC, Mellick GD, Le Couteur DG. Parkinson’s disease, pesticides, and glutathione transferase polymorphisms. Lancet. 1998;352:1344–1346
  25. Wahner AD, Glatt CE, Bronstein JM, Ritz B. Glutathione S-transferase mu, omega, pi, and theta class variants and smoking in Parkinson’s disease. Neurosci Lett. 2007;413:274–278
  26. Nishimura M, Kuno S, Kaji R, Yasuno K, Kawakami H. Glutathione-S-transferase-1 and interleukin-1beta gene polymorphisms in Japanese patients with Parkinson’s disease. Mov Disord. 2005;20:901–902
  27. Whitbread AK, Mellick GD, Silburn PA, Le Couteur DG, Board PG. Glutathione transferase omega class polymorphisms in Parkinson disease. Neurology. 2004;62:1910–1911
  28. Morens DM, Grandinetti A, Reed D, White LR, Ross GW. Cigarette smoking and protection from Parkinson’s disease: false association or etiologic clue?. Neurology. 1995;45:1041–1051
  29. Castagnoli K, Murugesan T. Tobacco leaf, smoke and smoking, MAO inhibitors, Parkinson’s disease and neuroprotection; are there links?. Neurotoxicology. 2004;25:279–291
  30. Deng Y, Newman B, Dunne MP, Silburn PA, Mellick GD. Case-only study of interactions between genetic polymorphisms of GSTM1, P1, T1 and Z1 and smoking in Parkinson’s disease. Neurosci Lett. 2004;366:326–331

☆ Other members of the Study Group are listed in the Appendix.

☆☆ The review of this paper was entirely handled by an Associate Editor, Eng-King Tan.

PII: S1353-8020(10)00086-6

doi: 10.1016/j.parkreldis.2010.04.009

Parkinsonism & Related Disorders
Volume 16, Issue 7 , Pages 447-452 , August 2010

Article Tools